Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells
- PMID: 3033261
- PMCID: PMC254104
- DOI: 10.1128/JVI.61.5.1310-1317.1987
Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells
Abstract
Epstein-Barr virus (EBV) isolates show sequence divergence in the BamHI YH region of the genome which encodes the nuclear antigen EBNA 2, a protein thought to be involved in the initiation of virus-induced B-cell transformation; type A isolates (such as B95-8 EBV) encode a 82- to 87-kilodalton EBNA 2A protein, whereas type B isolates (such as AG876 EBV) encode an antigenically distinct 75-kilodalton EBNA 2B protein. In the present work 12 type A isolates and 8 type B isolates have been compared for their ability to transform resting human B cells in vitro into permanent lymphoblastoid cell lines. Although the kinetics of initial focus formation was not markedly dependent upon the EBNA 2 type of the transforming virus, on subsequent passage type A virus-transformed cells (type A transformants) yielded cell lines much more readily than did type B transformants. Direct comparison between the two types of transformant revealed clear differences in several aspects of growth phenotype. Compared with type A transformants, cell lines established with type B virus isolates consistently displayed an unusual growth pattern with poor survival of individual cells shed from lymphoblastoid clumps, a lower growth rate and a greater sensitivity to seeding at limiting dilutions, and a significantly lower saturation density that could not be corrected by supplementation of the medium with culture supernatant containing B-cell growth factors. This is the first direct evidence that, in EBV-transformed B-cell lines, the EBNA 2 protein plays a continuing role in determining the cellular growth phenotype.
Similar articles
-
New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.J Gen Virol. 1987 Nov;68 ( Pt 11):2853-62. doi: 10.1099/0022-1317-68-11-2853. J Gen Virol. 1987. PMID: 2824665
-
Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.J Virol. 1989 Mar;63(3):1031-9. doi: 10.1128/JVI.63.3.1031-1039.1989. J Virol. 1989. PMID: 2536817 Free PMC article.
-
Cell growth effects of Epstein-Barr virus leader protein.J Gen Virol. 1992 Jun;73 ( Pt 6):1547-51. doi: 10.1099/0022-1317-73-6-1547. J Gen Virol. 1992. PMID: 1318948
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
-
Epstein-Barr virus latent genes.Exp Mol Med. 2015 Jan 23;47(1):e131. doi: 10.1038/emm.2014.84. Exp Mol Med. 2015. PMID: 25613728 Free PMC article. Review.
Cited by
-
Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.Biomark Res. 2021 May 6;9(1):34. doi: 10.1186/s40364-021-00286-9. Biomark Res. 2021. PMID: 33958003 Free PMC article. Review.
-
Lifestyle, Epstein-Barr virus infection, and other factors could impede nasopharyngeal cancer survivorship: a five-year cross-sectional study in North Eastern India.Virusdisease. 2022 Dec;33(4):371-382. doi: 10.1007/s13337-022-00789-5. Epub 2022 Nov 8. Virusdisease. 2022. PMID: 36447816 Free PMC article.
-
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.PLoS Pathog. 2022 Oct 3;18(10):e1010868. doi: 10.1371/journal.ppat.1010868. eCollection 2022 Oct. PLoS Pathog. 2022. PMID: 36190982 Free PMC article.
-
Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.J Virol. 2018 Oct 12;92(21):e00813-18. doi: 10.1128/JVI.00813-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30089703 Free PMC article.
-
Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells.J Virol. 1994 Nov;68(11):7490-6. doi: 10.1128/JVI.68.11.7490-7496.1994. J Virol. 1994. PMID: 7933132 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources